Galaxy Medicare IPO GMP: Day 1 IPO Live Updates

September 10, 2025
Posted by: sachet
Category: IPO

Check Expert’s Verdicts on Galaxy Medicare IPO

The Galaxy Medicare IPO GMP is ₹1 as of 10th September 2025. It is a bookbuilding IPO of ₹22.31 crores. This is an entirely fresh issue of 0.33 crore shares, and an offer for sale of 0.08 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 17th September 2025. The face value of Galaxy Medicare shares stands at ₹10 per share, and the IPO price band is set at ₹51.00 to ₹54.00 per share. Retail investors can bid for a minimum of 2 lots of 4,000 shares worth ₹2,16,000.

Table of Contents

Galaxy Medicare IPO Grey Market Premium

As of 10th September 2025, Galaxy Medicare IPO GMP stands at ₹11 per share. Thus, the estimated listing price would be ₹182. This indicates that the estimated listing gain in this IPO could be 6.43%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Galaxy Medicare IPO GMP updates.

GMP Date	IPO Price	GMP	Estimated Listing Price	Estimated Listing Gains
10-09-2025	₹54.00	₹1.00	₹55.00	1.85%
09-09-2025	₹54.00	₹1.00	₹55.00	1.85%
08-09-2025	₹54.00	₹0.00	₹54.00	0.00%

Galaxy Medicare IPO Details

IPO Open Date	10th September 2025
IPO Close Date	12th September 2025
IPO Allotment Date	15th September 2025
Refund Initiation	16th September 2025
Issue Size	41,32,000 shares(aggregating up to ₹22.31 Cr)
Fresh Issue	31,00,000 shares(aggregating up to ₹16.74 Cr)
Offer For Sale	8,24,000 shares of ₹10(aggregating up to ₹4.45 Cr)
Face Value	₹10 per share
Lot Size	2,000 shares
Issue Price Band	₹51.00 to ₹54.00 per share
Issue Type	Bookbuilding IPO
Listing At	NSE & SME
Listing Date	17th September 2025

Explanation

Galaxy Medicare IPO: Galaxy Medicare Limited has declared that the issue price band is set at ₹51.00 to ₹54.00 per share. With this IPO, the company allows retail investors to bid for two lots of 4,000 shares worth ₹2,16,000. The face value of Galaxy Medicare Limited shares is ₹10 per share. The shares of Galaxy Medicare Limited will be listed on NSE and SME on its tentative listing day, 17th September 2025. Scroll down to check GMP updates and Galaxy Medicare IPO reviews.

Objectives of the Galaxy Medicare IPO

The primary aim of the Galaxy Medicare IPO is to raise ₹22.31 crores. On the other hand, Galaxy Medicare has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Galaxy Medicare IPO.

To fund the Capital Expenditure requirement towards the purchase of machinery for the existing manufacturing facility at Bhubaneshwar, Odisha
To fund the working capital requirements
To General Corporate Purposes
To meet the offer-related expenses

Galaxy Medicare IPO Registrar

Cameo Corporate Services Limited is the registrar of the Galaxy Medicare IPO, responsible for managing the IPO allotment procedure and refund initiation. For any queries regarding the Galaxy Medicare allotment and refund, you can contact Cameo Corporate Services Limited at cameo@cameoindia.com or +91-44-28460390.

Galaxy Medicare IPO Review

The Galaxy Medicare IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Galaxy Medicare Limited’s revenue increased by 15.32% from ₹32.03 crores in March 2023 to ₹36.94 crores in March 2024. Moreover, the company’s PAT rose by 136.30% from ₹1.57 crores to ₹36.94 crores. Investors can analyse other relevant factors and make a decision accordingly.

Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Galaxy Medicare IPO or not.

Galaxy Medicare Limited Technicals

Key Indicators	Value
PE Ratio (Price-to-Earnings)	17.28
EPS (Earnings Per Share)	3.12
RoNW	23.85%
ROCE	23.80
ROE	23.85
EBITDA Margin	–
Price to Book Value	3.84
Market Capitalisation	₹81.93 Cr

The PE ratio of Galaxy Medicare Limited shares is 17.28, and its Earnings Per Share (EPS) stands at ₹3.12. Thus, the Galaxy Medicare IPO can potentially deliver gains on its tentative listing date, 17th September 2025.

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Galaxy Medicare Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics.

Indicators	Pre-IPO	Post-IPO
PE Ratio	17.28	2.25
EPS	3.12	2.25

Galaxy Medicare Limited IPO Peer Comparison

Company Name	EPS	P/E Ratio	RoNW	Face value	Revenue
Galaxy Medicare Limited	2.84	17.28	10.25	₹10	36.94
Adeshwar Meditex	1.43	12.59	5.17	₹10	79.98
KMS Medisurgi	1.33	95.11	5.44	₹10	13.98

FAQs on Galaxy Medicare IPO

What is the Galaxy Medicare IPO GMP?

Ans. Currently, on 10th September 2025, the Galaxy Medicare (Grey Market Premium) stands at ₹1. This indicates that the estimated listing price could be ₹55 per share.

What is the issue price of the Galaxy Medicare IPO?

Ans. The Galaxy Medicare IPO price is set at ₹51.00 to ₹54.00 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 4,000 shares, worth ₹2,16,000. Moreover, HNIs are required to bid for a minimum of 3 lots (6,000 shares) worth ₹3,24,000.

Who is the registrar of the Galaxy Medicare IPO?

Ans. Cameo Corporate Services Limited is the registrar of the Galaxy Medicare IPO, responsible for managing the IPO allotment procedure and refund initiation. For any queries regarding the Galaxy Medicare allotment and refund, you can contact Cameo Corporate Services Limited at cameo@cameoindia.com or +91-44-28460390.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Galaxy Medicare IPO, download the Galaxy Medicare IPO RHP and Galaxy Medicare IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.